Hepatitis Testing Market Set for Steady Growth at 5.93% CAGR Through 2034: DelveInsight | Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Oers, Danaher Corporation, AdvaCare Pharma, Alpine Biomedicals Pvt. Ltd., Siemens Healthineers and Others

The global hepatitis testing market is poised for strong, sustained expansion, driven by the rising global burden of hepatitis infections, growing adoption of point-of-care diagnostics, and accelerating product innovation across molecular assays, automated immunoassays, and rapid diagnostic platforms.

Key Takeaways (TL;DR)

• The global hepatitis testing market is projected to grow from USD 3,470.08 million in 2025 to USD 5,785.24 million by 2034, reflecting a CAGR of 5.93% during 2026-2034.
• North America is expected to dominate the market in 2025, capturing around 42% share, supported by the high prevalence of chronic Hepatitis B and C, mandatory blood donor screening programs, technological advancements in molecular diagnostics, and strong public awareness of liver health.
• Hepatitis testing market growth is underpinned by the rising global prevalence of hepatitis infections and their complications such as liver cirrhosis and liver cancer, expansion of blood donation and blood screening programs, increasing awareness and government-led screening initiatives, and growing adoption of point-of-care testing in resource-limited settings.
• Technological trends include the integration of Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR)-based molecular testing, Chemiluminescence Immunoassay (CLIA), rapid diagnostic tests, CRISPR-based diagnostics, next-generation sequencing (NGS), and AI-driven diagnostic platforms that enhance testing accuracy, speed, and accessibility.
• By product type, the reagents & kits category is estimated to account for the largest market share at approximately 68% in 2025, while by technology, the ELISA segment dominates with a market share of around 60%, and the Hepatitis B disease type leads the disease segment.
• Key companies operating in the hepatitis testing market include Abbott, F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Bio-Merieux, Hologic Inc., Danaher Corporation, AdvaCare Pharma, Alpine Biomedicals Pvt. Ltd., Siemens Healthineers, SD Biosensor Inc., OraSure Technologies Inc., Creative Diagnostics, SSI Diagnostica A/S, InTec Products Inc., BTNX Inc., ACON Laboratories Inc., Altona Diagnostics GmbH, Bruker Corporation, Mikrogen GmbH, Fortress Diagnostics, and others.
• Recent developments focus on advanced molecular diagnostic authorizations, CE-IVD PCR kit portfolio completions, next-generation point-of-care testing platforms, and expanded deployment across both developed and high-disease-burden emerging markets to support broader hepatitis surveillance and elimination goals.

For more recent advancements in this landscape, visit https://www.delveinsight.com/sample-request/hepatitis-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=xpr

Hepatitis Testing Market Overview and Growth Outlook

The hepatitis testing market is forecast to expand from USD 3,470.08 million in 2025 to USD 5,785.24 million by 2034, growing at a CAGR of 5.93% from 2026 to 2034. This trajectory reflects the increasing clinical and public health emphasis on early detection of hepatitis infections, broader access to laboratory and point-of-care diagnostics, and sustained investment in diagnostic infrastructure across both mature and emerging healthcare markets. The growing burden of chronic Hepatitis B and C, which collectively affect hundreds of millions of people globally, continues to create urgent demand for accurate, scalable, and accessible testing solutions.

Dive deeper into the Hepatitis Testing market trends @ https://www.delveinsight.com/sample-request/hepatitis-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=xpr

Hepatitis Testing Market Regional Insights

North America is anticipated to hold the largest share of approximately 42% of the global market in 2025, driven by the high prevalence of chronic Hepatitis B and C, extensive government-supported screening initiatives, well-developed healthcare and laboratory infrastructure, and strong adoption of advanced molecular and automated immunoassay platforms.

Furthermore, Europe is expected to remain a key growth engine, supported by ongoing hepatitis B and C infection burdens, expanding public health screening programs, and a growing emphasis on early detection to prevent progression to liver cancer. Asia-Pacific is identified as the fastest-growing regional market, propelled by the large pool of chronically infected individuals in countries such as China, India, and Japan, rising government-led hepatitis elimination programs, and the increasing adoption of rapid point-of-care testing across both urban and underserved settings.

For in-depth regional analysis, visit https://www.delveinsight.com/sample-request/hepatitis-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=xpr

Hepatitis Testing Market Segmentation

• By Product Type: Reagents & Kits, Instruments
• By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Test, Polymerase Chain Reaction (PCR), Chemiluminescence Immunoassay (CLIA), Others
• By Disease Type: Hepatitis B, Hepatitis C, Hepatitis A, Hepatitis D, Hepatitis E
• By Test Type: Antigen Test, Antibody Test, Nucleic Acid Test, Genotype Test
• By End-User: Hospitals & Clinics, Diagnostic Laboratories, Others
• By Geography: North America, Europe, Asia-Pacific, Rest of the World

Hepatitis Testing Market Competitive Landscape

The competitive landscape is moderately concentrated, with established global diagnostics leaders complemented by a growing ecosystem of regional and technology-focused emerging companies.

Key global players include Abbott, F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Bio-Merieux, Hologic Inc., Danaher Corporation, AdvaCare Pharma, Alpine Biomedicals Pvt. Ltd., Siemens Healthineers, SD Biosensor Inc., OraSure Technologies Inc., Creative Diagnostics, SSI Diagnostica A/S, InTec Products Inc., BTNX Inc., ACON Laboratories Inc., Altona Diagnostics GmbH, Bruker Corporation, Mikrogen GmbH, Fortress Diagnostics, and others.

Which company is expected to dominate the Hepatitis Testing market? Know @ https://www.delveinsight.com/sample-request/hepatitis-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=xpr

Key Features of DelveInsight's Hepatitis Testing Market Report

• Detailed market sizing and forecasts from 2025 to 2034 at global and regional levels, including revenue projections and CAGR analysis.
• Granular assessment of market contribution by major regions such as North America, Europe, Asia-Pacific, and the Rest of the World.
• Coverage of key product categories, including reagents & kits and diagnostic instruments, across a full spectrum of testing technologies such as ELISA, PCR, CLIA, and rapid diagnostic tests.
• Evaluation of usage across care settings, including hospitals and clinics, diagnostic laboratories, and other clinical environments where hepatitis testing is routinely performed.
• Detailed discussion on why North America is expected to dominate, including drivers such as high hepatitis infection prevalence, advanced diagnostic technology adoption, mandatory blood screening mandates, and robust public awareness campaigns.
• Insight into Europe's and Asia-Pacific's growth drivers, including expanding hepatitis C and B infection burdens, government-led elimination initiatives, and rising demand for affordable point-of-care diagnostics in high-prevalence populations.
• Systematic coverage of demand drivers such as growing global hepatitis B and C infection rates, increasing blood donation and blood safety screening volumes, and continuous product development activities by leading diagnostic companies.
• Identification of evolving opportunities around AI-powered diagnostic platforms, CRISPR-based assays, mobile health and telemedicine integration, next-generation sequencing, and biosensor technologies for point-of-care hepatitis detection.
• Profiles and strategic analysis of major companies in the Hepatitis Testing landscape.
• Assessment of market concentration, technology adoption trends, and strategic levers for market entry or expansion.

Request Custom Analysis or Speak to Our Analyst @ https://www.delveinsight.com/sample-request/hepatitis-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=xpr

Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email: info@delveinsight.com
Phone: +14699457679
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe, helping them stay ahead of the growth curve.

This release was published on openPR.